RPE65 and Leber congenital amaurosis: Recently, AAV2-mediated gene transfer of RPE65 in patients affected with Leber's Congenital Amaurosis (LCA, type 2; OMIM 204100) achieved stable improvement of visual and retinal function [14], [15], [16], [17], [18], [19], [20], [21].